Table 3

The 30-d postoperative outcomes between patients with 1 to 2 stents and controls.

30-d Medical Complications1–2 Stents
(n = 17,087)
Control
(n = 707,396)
P Value1–2 Stents vs Control,
Adjusted OR (95% CI)
P Value
Major
 Pulmonary embolus64 (0.4%)1968 (0.3%)0.0230.84 (0.65–1.08)0.189
 Pneumonia190 (1.1%)3775 (0.5%)<0.0010.97 (0.83–1.12)0.671
 CVA38 (0.2%)874 (0.1%)<0.0010.76 (0.54–1.04)0.105
MI 93 (0.5%) 776 (0.1%) <0.001 2.15 (1.70–2.69) <0.001
 Sepsis128 (0.7%)2760 (0.4%)<0.0010.91 (0.75–1.09)0.299
 Death33 (0.2%)601 (0.1%)<0.0010.94 (0.64–1.33)0.752
Minor
 AKI235 (1.4%)4192 (0.6%)<0.0010.95 (0.83–1.09)0.495
 UTI446 (2.6%)11,275 (1.6%)<0.0010.94 (0.85–1.03)0.194
 Wound complications383 (2.2%)11,031 (1.6%)<0.0010.95 (0.86–1.06)0.381
Transfusion 221 (1.3%) 3776 (0.5%) <0.001 1.25 (1.08–1.44) 0.002
DVT 83 (0.5%) 2962 (0.4%) 0.201 0.74 (0.58–0.91) 0.007
30-d Readmission 1279 (7.5%) 29,761 (4.2%) <0.001 1.09 (1.02–1.16) 0.006
  • Abbreviations: AKI, acute kidney injury; CVA, cerebrovascular accident; DVT, deep vein thrombosis; MI, myocardial infarction; UTI, urinary tract infection.

  • Note: Values in bold denote statistical significance determined by P < 0.05.